bioAffinity Technologies (BIAF) Cash from Investing Activities (2023 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Cash from Investing Activities of -$5663.0 for Q1 2026, up 88.85% year-over-year from -$2998.7 in Q1 2025, and down 566200.0% quarter-over-quarter from -$1.0 in Q4 2025.
bioAffinity Technologies (BIAF) Cash from Investing Activities (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Cash from Investing Activities for 4 consecutive years, with -$5663.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 88.85% year-over-year to -$5663.0; the TTM figure through Mar 2026 stood at -$15445.0 (up 82.54% YoY), while the FY2025 annual figure was -$60568.0, up 23.41% from the prior year.
- Cash from Investing Activities declined to -$5663.0 in Q1 2026 per BIAF's latest filing, from -$1.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $13442.0 in Q4 2023 and bottomed at -$2.2 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$181131.8 across 4 years, with a median of -$9410.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities sank 632.58% — and 2025, when it surged 138.75%.
- bioAffinity Technologies' Cash from Investing Activities stood at $13442.0 in 2023, then tumbled by 100.01% to -$1.0 in 2024, then changed by 0.0% to -$1.0 in 2025, then plunged by 566200.0% to -$5663.0 in 2026.
- Business Quant data shows BIAF's Cash from Investing Activities at -$5663.0 in Q1 2026, -$1.0 in Q4 2025, and $3646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | -89,970.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89,970.00 |
| Jun 30, 2026 | -89,970.00 |
| Mar 31, 2026 | -5,663.00 |
| Mar 31, 2026 | -5,663.00 |
| Dec 31, 2025 | -1.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 3,646.00 |
| Sep 30, 2025 | 3,646.00 |
| Jun 30, 2025 | -13,427.00 |
| Jun 30, 2025 | -13,427.00 |
| Mar 31, 2025 | -50,786.00 |
| Mar 31, 2025 | -50,786.00 |
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | -9,410.00 |
| Sep 30, 2024 | -9,410.00 |
| Jun 30, 2024 | -28,285.00 |
| Jun 30, 2024 | -28,285.00 |
| Mar 31, 2024 | -41,387.00 |
| Mar 31, 2024 | -41,387.00 |